LRRK2 Pathways Leading to Neurodegeneration

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are a significant cause of inherited Parkinson's disease (PD).
• The LRRK2 gene locus also contains a risk factor for sporadic PD, indicating a broader role in the disease.
• The LRRK2 protein possesses domains suggesting involvement in cellular signaling, notably a kinase domain.

Purpose of the Study:

• To review the fundamental, yet unresolved, aspects of LRRK2 biology and normal function.
• To elucidate the relationship between LRRK2's normal function and the pathophysiology of Parkinson's disease.
• To discuss LRRK2 as a potential therapeutic target for PD, particularly through kinase inhibition.

Main Methods:

• Literature review focusing on LRRK2 genetics, protein interactions, and signaling pathways.
• Analysis of studies investigating LRRK2's role in both familial and sporadic Parkinson's disease.
• Synthesis of current knowledge on LRRK2 function and its implications for PD pathogenesis.

Main Results:

• LRRK2 mutations are strongly associated with familial PD and contribute to sporadic PD risk.
• LRRK2's kinase domain and interactions with other PD-implicated proteins suggest a central role in parkinsonism.
• Kinase inhibition is a primary therapeutic strategy being explored for LRRK2-related PD.

Conclusions:

• Understanding LRRK2's normal function is crucial for deciphering its role in PD.
• LRRK2 represents a key molecular player in the pathways underlying Parkinson's disease.
• Further research into LRRK2 biology is essential for developing effective PD therapies.